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Abstract To study the time course of demineralization
and fracture incidence after spinal cord injury (SCI), 100
paraplegic men with complete motor loss were investi-
gated in a cross-sectional study 3 months to 30 years
after their traumatic SCI. Fracture history was assessed
and veriﬁed using patients’ ﬁles and X-rays. BMD of the
lumbar spine (LS), femoral neck (FN), distal forearm
(ultradistal part = UDR, 1/3 distal part = 1/3R), dis-
tal tibial diaphysis (TDIA), and distal tibial epiphysis
(TEPI) was measured using DXA. Stiﬀness of the cal-
caneus (QUI.CALC), speed of sound of the tibia
(SOS.TIB), and amplitude-dependent SOS across the
proximal phalanges (adSOS.PHAL) were measured
using QUS. Z-Scores of BMD and quantitative ultra-
sound (QUS) were plotted against time-since-injury and
compared among four groups of paraplegics stratiﬁed
according to time-since-injury (<1 year, stratum I;
1–9 years, stratum II; 10–19 years, stratum III; 20–
29 years, stratum IV). Biochemical markers of bone
turnover (deoxypyridinoline/creatinine (D-pyr/Cr),
osteocalcin, alkaline phosphatase) and the main
parameters of calcium phosphate metabolism were
measured. Fifteen out of 98 paraplegics had sustained a
total of 39 fragility fractures within 1,010 years of
observation. All recorded fractures were fractures of the
lower limbs, mean time to ﬁrst fracture being 8.9 ± 1.4
years. Fracture incidence increased with time-after-SCI,
from 1% in the ﬁrst 12 months to 4.6%/year in para-
plegics since >20 years (p<.01). The overall fracture
incidence was 2.2%/year. Compared with nonfractured
paraplegics, those with a fracture history had been in-
jured for a longer time (p<.01). Furthermore, they had
lower Z-scores at FN, TEPI, and TDIA (p<.01 to
<.0001), the largest diﬀerence being observed at TDIA,
compared with the nonfractured. At the lower limbs,
BMD decreased with time at all sites (r=.49 to .78, all
p<.0001). At FN and TEPI, bone loss followed a log
curve which leveled oﬀ between 1 to 3 years after injury.
In contrast, Z-scores of TDIA continuously decreased
even beyond 10 years after injury. LS BMD Z-score
increased with time-since-SCI (p<.05). Similarly to
DXA, QUS allowed diﬀerentiation of early and rapid
trabecular bone loss (QUI.CALC) vs slow and con-
tinuous cortical bone loss (SOS.TIB). Biochemical
markers reﬂected a disproportion between highly ele-
vated bone resorption and almost normal bone forma-
tion early after injury. Turnover declined following a log
curve with time-after-SCI, however, D-pyr/Cr remained
elevated in 30% of paraplegics injured >10 years. In
paraplegic men early (trabecular) and persistent (corti-
cal) bone loss occurs at the lower limbs and leads to an
increasing fracture incidence with time-after-SCI.
Keywords Biochemical bone markers Æ Bone loss Æ
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Introduction
Bone loss after spinal cord injury (SCI) leads to a high
incidence of fractures of the lower limbs in paraplegics
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[1, 2]. Today, 60 years after Albright’s ﬁrst description
of disuse osteoporosis [3], many questions regarding the
cause, pattern, and time course of demineralization after
SCI are still unresolved.
A few longitudinal studies have addressed the issue of
bone turnover [4] or bone loss [5, 6, 7, 8] after SCI.
Taken together, they suggest an extensive early demin-
eralization after medullary lesion. These studies have
usually been conducted on a small numbers of patients,
and/or their duration was limited to the ﬁrst few months
after SCI, and/or they included an heterogeneous patient
population (men and women, paraplegics and tetraple-
gics, complete and incomplete SCI), and/or they did not
adjust BMD for age and time-since-injury [9, 10, 11, 12,
13, 14].
The duration of bone loss after SCI and the infra- and
supralesional, trabecular as well as cortical, bone loss
patterns remain unknown in paraplegic men. Although
the most common fractures after SCI are fractures of
femur and tibia [15], no tibial BMD data have been
available so far in these patients. In addition the question
of whether alterations in qualitative bone properties
(QUS data) are conﬁned to the paralyzed limbs or aﬀect
the whole skeleton remains open, and data in patients
after SCI are limited to the calcaneus [16].
Recent technical developments give a more detailed
insight into the pathogenesis of osteoporosis in SCI
patients. Regional high-resolution DXA allows infra-
and supralesional measurements of trabecular and cor-
tical sites. Bone mineral density measurements at distal
tibia, a standardized method established earlier by our
group [17] to assess bone loss at a predominantly cor-
tical site—the tibial diaphysis—and in an area contain-
ing a substantial amount of trabecular bone—the distal
tibial epiphysis—in one single, normally weight-bearing,
bone, are of particular interest in SCI patients. Quanti-
tative ultrasound (QUS) may provide additional infor-
mation with respect to qualitative bone properties such
as elasticity and microstructure [18].
The aim of this cross-sectional study was to docu-
ment the fracture history, the regional evolution of
BMD (infra- and supralesional / trabecular and corti-
cal) and QUS parameters as well as biochemical
parameters of bone turnover in a large and homoge-
neous group of SCI patients.
Patients and methods
One hundred paraplegic men attending the outpatient clinic of the
Swiss Paraplegic Center (SPC), Nottwil, Switzerland, were inves-
tigated between November 1997 and June 1999.
Inclusion criteria were male gender; complete motor post-
traumatic medullary lesion between T1–L3 with total motor and
sensory loss (corresponding to stage A according to the Frankel
classiﬁcation), or with total motor and partial sensory loss (Frankel
stage B); age between 18 and 60 years; traumatic event leading to
paraplegia after the age of 17.
Exclusion criteria were use of drugs aﬀecting bone metabolism
(ﬂuorides, bisphosphonates, vitamin D, calcitriol, anabolic steroids,
chronic glucocorticoid use for more than 3 months, thyroid hor-
mones, cytostatics, antiandrogens, lithium, chronic use of antiepi-
leptics), known diseases aﬀecting bone (algodystrophy, spondylitis
ankylosans, rheumatoid arthritis, Paget’s disease, osteogenesis im-
perfecta, hyperthyroidism, hyperparathyroidism, hypogonadism,
hypercortisolism, malignant tumors, renal bone disease, chronic
liver disease and post-transplantation bone disease).
All clinical investigations were conducted in accordance with
the Declaration of Helsinki, and the present study protocol was
approved by the Ethics Committee of the Canton of Lucerne
(Switzerland). All patients gave their written informed consent
before entering the study.
Fracture history
Subjects were asked about their fracture history and the exact
mechanism leading to fracture. Traumatic fractures were distin-
guished from low-energy trauma events (i.e., osteoporotic fracture).
Data were conﬁrmed based on their medical records and X-rays.
Dual-energy X-ray absorptiometry (DXA)
The bone mineral density (BMD) of the lumbar spine (LS, second
to fourth lumbar vertebrae), femoral neck (FN), distal forearm
(ultradistal part = UDR, 1/3 distal part = 1/3R), distal tibial
diaphysis (TDIA) and distal tibial epiphysis (TEPI) [17] was mea-
sured using DXA (Hologic QDR 4500A; Hologic, Bedford, MA).
BMD was expressed as g/cm2 of hydroxyapatite and as Z-score
(SD from the mean of a healthy male population of the same age).
Four hundred normal Caucasian men, 20–80 years of age, living
in the area of Berne, served as reference population. Peak bone
mass (mean value ± SD) was 1.100 ± 0.139 g/cm2 at LS,
0.937 ± 0.121 g/cm2at FN, 0.548 ± 0.060 g/cm2 at UDR,
0.817 ± 0.053 g/cm2at 1/3R, 0.927 ± 0.119 g/cm2 at TEPI,
1.375 ± 0.118 g/cm2 at TDIA. All scans were performed according
to the manufacturer’s guidelines. Peripheral bone measurements
were carried out at the nondominant limb. Quality control was
performed daily (anthropometric spine phantom supplied by the
manufacturer): overall precision error was 0.3% in vitro and mean
precision error in our hands is 1.1% in vivo (LS).
Quantitative ultrasound (QUS) of calcaneus, tibia, and phalanges
Z-scores of all QUS measurements were derived from the manu-
facturer’s reference database.
Calcaneus
The quantitative ultrasound index (QUI.CALC; arbitrary units
(AU)) was measured using the Sahara device (Hologic, Bedford,
MA). QUI.CALC integrates the parameters, speed of sound
(SOS.CALC; m/s) and broadband ultrasound attenuation
(BUA.CALC; dB/MHz) across the calcaneus according to the
formula QUI=(0.41·BUA)+(0.41xSOS))571. Typically, QUI
ranges from 80 to 120 AU in healthy young men. In our hands,
precision error is 1.8 ± 0.8% (6 heels measured 11 times over
14 days).
Tibia
Speed of sound (SOS.TIB; m/s) was measured at the tibial crest
using a Sound Scan 2000 (Myriad Ultrasound Systems, Rehovot,
Israel), according to the manufacturer’s speciﬁcations. The average
of the ﬁve highest readings was considered as the measured value.
Short-term in vivo precision error in our hands is around 2%.
Reported standardized coeﬃcient of variation for this method is
1.6% [19].
181
Phalanges
Amplitude-dependent speed of sound SOS (adSOS.PHAL; m/s)
was measured across the 2nd to 5th proximal phalanges of the
nondominant hand using the Sonic DBM 1200 Device (IGEA,
Italy). Short-term in vivo precision error in our hands was around
1%—i.e., similar to that reported by others [20].
Biochemical parameters
Blood
Venous blood was drawn in the morning after an overnight fast. In
all patients, laboratory analyses were performed either within the
2 h after drawing of blood or on thawed plasma that had been
stored at )80C prior to analyses. Serum concentrations of total
calcium (Ca; normal range (NR) 2.15–2.55 mmol/l), phosphorus
(P; NR 0.87–1.45 mmol/l), creatinine (Cr; NR 44–80 lmol/l), and
plasma total alkaline phosphatase (ALP; NR 39–117 U/l) were
measured using standard laboratory techniques and normal ranges
from the biochemistry laboratory of the University Hospital of
Berne. Ionized calcium (Ca++; NR 1.15–1.30 mmol/l) was mea-
sured in whole blood using an ion-selective electrode (Ciba Corning
Diagnostics, Medford, MA). The serum concentrations of intact
PTH (PTH; Allegro, Nichols Institute Diagnostics, San Juan
Capistrano, CA; NR 10–65 pg/ml), 25-hydroxyvitamin D
(25OHD; Nichols Institute Diagnostics; NR 6–40 ng/ml), osteo-
calcin (OC; Nichols Institute Diagnostics; NR 11.1–32.2 ng/ml),
and serum-free testosterone (T; Diagnostic Systems Laboratories,
TX; NR 8.7–54.7 pg/ml) were measured by radio-immunoassays
and manufacturers’ normal ranges.
Urine
Two-hour fasting urine samples (second morning voided urine)
were analyzed for calcium (atomic absorptiometry) and creatinine
(standard colorimetric assay based upon the Jaﬀe method). Urinary
deoxypyridinoline (D-pyr) was measured by reverse-phase ion-
paired HPLC (Crosslinks, BioRad, Germany). Results were ex-
pressed as ratios of Ca/Cr (NR 0.1–0.32 mmol/mmol) and D-pyr/
Cr (NR 9–20 nmol/mmol), based on manufacturer’s normal range.
Twenty-four-hour urinary excretion of calcium (UCaxV; NR 2.5–
8.0 mmol/24 h) and creatinine (UCrxV; NR 6,000–18,000 mmol/
24 h) was measured using standard laboratory techniques.
Nutrition and lifestyle questionnaire
Dietary calcium intake was determined using food frequency
questionnaires and indicated as mg of calcium per day. Current
alcohol consumption was expressed as standard drinks per day.
Lifetime amount of smoking was presented in pack-years,
smokers were deﬁned as having smoked 5 pack-years or more in
their lives. Assessment of physical activity included estimation of
daily hours of sitting, current standing activities (min/day), and
total time spent with sportive activities (hr/week). Data on
duration of initial bed rest after SCI was taken from medical
records.
Statistical analysis
Statistics were performed using a statistical software package
(Statview 4.1; Abacus Concept, Berkeley, CA). Values are given as
mean ± SEM. In accordance with a recently published study [11],
patients were stratiﬁed into the following four groups according to
time-since-injury: i.e., <1 year (stratum I), 1 to 9 years (stratum
II), 10 to 19 years (stratum III), and 20 to 29 years (stratum IV)
postinjury. Linear or —where more appropriate—logarithmic
regression was used to describe the relationship between bio-
chemical markers, bone density, and quantitative ultrasound
parameters, on the one hand, and time-since-SCI, on the other.
Multiple regression analysis was used to deﬁne determinants of
biochemical indices, BMD, and QUS.
Fracture history was documented based on total number of
fractures and fracture episodes: multiple fractures occurring at a
single traumatic event were counted as one fracture episode.
Fractures due to a high-energy trauma and fractures that occurred
at the time of SCI were not included in the analysis. The rate of
anamnestic fractures (%) was calculated for each stratum by time-
since-injury.
Results
Patient characteristics
One hundred male patients with complete motor post-
traumatic medullary lesion between T1–L3 and either
total motor and sensory loss (n=94, Frankel stage A) or
total motor and partial sensory loss (n=6, Frankel B)
were screened for participation to this cross-sectional
study (Table 1). Of the patients, 21% had a lesion T1–
T5, 44% T6–T10, and 35% T11–L3.
Mean (±SEM) estimated calcium intake was
1,293 ± 67.3 mg/day (range 250–4,260 mg/day). Pa-
tients spent an average of 13.5 ± 0.3 h per day sitting in
the wheelchair (range 6.0–18.0). They did (n=51) or did
not (n=49) regularly perform passive weight-bearing
standing with the aid of a standing device: 22 men re-
ported standing for less than 30 min per day, whereas 24
men reported doing so for 30–60 min and 5 for more
than 1 h. Sportive activities (e.g., basketball, hand-bik-
ing, swimming, tennis, weight lifting, skiing) were per-
formed by 67 men; 42 did so with high intensity (>3 h/
week), and 25 with moderate intensity (<3 h/week).
Fourty-nine men were smokers. Alcohol consumption
was low to moderate ( £ 2 standard drinks / day) in 88
men, and more than 2 standard drinks / day in 12 men.
Two patients were excluded based on the exclusion cri-
teria (one hypogonadism, one hyperparathyroidism).
Fracture history
Fifteen of the 98 paraplegic men included had sustained
22 episodes with a total of 39 fractures within 1,010
Table 1 Characteristics of study population (n=100). SCI spinal
cord injury
Parameter Mean ± SEM Median Patients’ range
Age (years) 38.0±0.97 37.3 18.3–59.9
Height (cm) 177.1±0.78 177.0 160–196
Weight (kg) 71.4±1.07 71.0 45–98
Body mass index (kg/m2) 22.7±0.31 22.7 15.4–30.1
Age at injury (years) 27.5±0.93 24.5 17.0–57.8
Duration of SCI (years) 10.4±0.79 9.5 0.1–29.5
Initial bed rest (months) 4.3±0.43 3.0 0.5–28.0
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years of observation (mean 10.4 ± 0.79 years observa-
tion per patient). Both the total number of individual
fractures as well as the number of fracture episodes in-
creased regularly with the number of years since injury
(Table 2; Fig. 1). Mean time to ﬁrst fracture after SCI
was 8.9 ± 1.4 years (median 8.5 years). Although most
fractures were due to a fall from the wheelchair, no
fracture of the upper limbs was registered: 9 femur (neck
3, shaft 3, supracondylar 3), 3 knee (condylar 2, patellar
1), 13 tibia, 9 ankle (ﬁbular 8, calcaneal 1), and 4 foot
(metatarsal 3, toe 1) fractures occurred. The mean yearly
fracture incidence increased signiﬁcantly (p<0.01) with
time-after-SCI from 1%/year (stratum I) to 4.6%/year
(stratum IV), with an overall mean fracture incidence of
2.2%.
Paraplegic men with fractures (n=15) had been
injured for a signiﬁcantly longer time (15.7 ± 1.9 vs
9.3 ± 0.8 years, p<0.01) than men without
fractures. There was no signiﬁcant diﬀerence between
the two groups with regard to age, calcium intake,
physical activity, smoking, or alcohol consumption ha-
bits.
Bone mineral density
Bone mineral density measurements were performed in
90/98 patients at the lumbar spine (LS), in 91/98 at the
radius (ultradistal radius UDR and shaft 1/3R), in 94/98
at the femoral neck (FN), in 93 and 92/98 at the tibial
diaphysis (TDIA) and tibial epiphysis (TEPI), respec-
tively. Not evaluable scans were due to metallic implants
(LS), positioning problems (UDR, 1/3R), periarticular
ossiﬁcation (FN), and positioning problems due to the
spasticity of the legs (TDIA, TEPI).
Individual BMD Z-scores as a function of time-after-
SCI are depicted in Fig. 2. The comparison of mean
BMD, Z-scores, and the number and percentage of
Table 2 Fracture incidence, BMD, and QUS, stratiﬁed by time-since-injury in 98 paraplegics (after exclusion of patients nos. 41 and 46
due to secondary osteoporosis). p Values are post hoc Fisher PLSD
Stratiﬁcation by time-since-injury (year) p Value ANOVA
Stratum I Stratum II Stratum III Stratum IV
<1 year 1–9 years 10–19 years 20–29 years
Number of paraplegics 16 38 31 13
Age, years (mean±SEM) 30.7±2.8 36.0±1.6a 40.5±1.3b,c 45.6±0.91d,e <0.0001
Fractures
Fracture incidence (%/year) 1 1.3 3.4 4.6 <0.01f
Bone mineral density
Lumbar spine
BMD, g/cm2 (mean ± SEM) 1.012±0.028 1.080±0.025 1.188±0.030g,h 1.160±0.058g <0.01
Z-Score, SD (mean ± SEM) )0.43±0.19 0.11±0.15 1.09±0.23d,e 1.00±0.42b,h <0.0001
Radius UD
BMD, g/cm2 (mean ± SEM) 0.530±0.015 0.531±0.010 0.550±0.011 0.546±0.019 0.4
Z-Score, SD (mean ± SEM) 0.02±0.24 0.01±0.15 0.52±0.20 0.44±0.32 0.15
Radius 1/3
BMD,g/cm2 (mean ± SEM) 0.805±0.021 0.825±0.009 0.847±0.010a 0.813±0.016 0.08
Z-Score SD (mean ± SEM) 0.00±0.41 0.40±0.17 0.97±0.20c 0.27±0.31 <0.05
Femoral neck
BMD, g/cm2 (mean ± SEM) 0.887±0.029 0.661±0.019d 0.634±0.029d 0.602±0.033d <0.0001
Z-Score, SD (mean ± SEM) )0.03±0.25 )1.65±0.17d )1.76±0.25d )1.76±0.28d <0.0001
Tibial epiphysis
BMD, g/cm2 (mean ± SEM) 0.870±0.028 0.446±0.016d 0.407±0.026d 0.391±0.028d <0.0001
Z-Score, SD (mean ± SEM) )0.34±0.22 )3.81±0.13d )4.00±0.21d )4.12±0.24d <0.0001
Tibial diaphysis
BMD, g/cm2 (mean ± SEM) 1.422±0.031 1.221±0.027d 1.091±0.037d,h 1.076±0.045d,h <0.0001
Z-Score, SD (mean ± SEM) 0.44±0.27 )1.29±0.23d )2.38±0.32d,h )2.49±0.39d,h <0.0001
Quantitative ultrasound
adSOS.PHAL
m/s 2,037±17 2,065±13 2,074±14 2,035±24 0.3
Z-Score (SD) )1.14±0.23 )0.71±0.18 )0.46±0.21 )0.94±0.44 0.3
QUI.CALC
AU 83±8 39±1d 37±2d 41±5d <0.0001
Z-Score (SD) )1.01±0.47 )3.68±0.09d )3.84±0.09d )3.79±0.15d <0.0001
SOS.TIB
m/s 4,026±35 3,982±21 3,886±29a,c 3,893±38a,c <0.01
Z-Score (SD) 0.46±0.29 0.23±0.18 )0.81±0.26g,h )0.80±0.34g,h <0.01
ap<0.05 vs <1 year;
bp<0.001 vs <1 year;
cp<0.05 vs 1–9 years;
dp<0.0001 vs <1 year;
ep<0.001 vs 1–9 years;
fby v-square test;
gp<0.01 vs <1 year;
hp<0.01 vs 1–9 years
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osteoporotic patients within the various strata postin-
jury is shown in Table 2.
At LS, a signiﬁcant positive correlation between
Z-scores and time-after-injury was observed (r=0.43;
p<0.0001). The mean lumbar Z-score was slightly neg-
ative in recently injured men (stratum I), identical to
age-matched normal controls between 1 and 9 years
postinjury (stratum II), and +1 SD above age-matched
normal controls after 10 years or more of injury.
At the radius, the Z-scores at both sites were com-
parable to age-matched normal controls in strata I and
II, and +0.5 to +1 SD above age-matched normal
controls after 10 years of injury.
At the lower limbs, BMD decreased dramatically
with time at all sites, correlation coeﬃcients ranging
from 0.49 to 0.78 (all p<0.0001). At FN and TEPI, bone
loss followed a log curve which leveled oﬀ between 1 and
3 years after injury. In contrast, Z-scores of TDIA de-
creased progressively even beyond 10 years after injury.
These results were tested for several possible determi-
nants of bone loss other than time-since-SCI: there were
no signiﬁcant correlations of BMD Z-scores at any site
with current calcium intake, alcohol consumption, cur-
rent standing, sportive activity, level of spinal cord lesion
(T1–T10 = high; T11–L3 = low) and presence or ab-
sence of spasticity. Only smokers (n=47) had signiﬁcantly
lower BMD Z-scores compared with nonsmokers
(n=51) at the infralesional sites FN (–1.7 ± 0.18 SD
vs –1.1 ± 0.18 SD; p<0.05), TEPI (–3.8 ± 0.23 SD vs –
2.9 ± 0.23 SD; p<0.01) and TDIA (–1.8 ± 0.26 SD vs –
1.1 ± 0.23 SD; p<0.05) but not at the supralesional LS
and forearm sites. Patients with anamnestic fractures after
SCI had signiﬁcantly lower Z-scores at the infralesional
sites FN (–2.3 ± 0.36 SD vs –1.3 ± 0.14 SD; p<0.01),
TEPI (–4.6 ± 0.34 SD vs –3.1 ± 0.18 SD; p<0.001) and
TDIA (–3.1 ± 0.40 SD vs –1.2 ± 0.18 SD; p<0.0001)
but not at the supralesional LS and forearm sites.
Quantitative ultrasound
Analogously to BMD at tibial epiphysis, Z-scores of
QUI.CALC decreased following a logarithmic curve
with time-since-injury which leveled oﬀ 6 to 12 months
postinjury, whereas Z-scores of SOS.TIB decreased
more linearly with time-after-injury, similarly to BMD
of the tibial diaphysis. Z-scores of ad.SOS.PHAL did
not signiﬁcantly change with time-after-injury over the
time period (Table 2; Fig. 3).
These results were tested for several possible deter-
minants of bone loss other than time-since-SCI: there
were no signiﬁcant correlations of QUS Z-scores at any
site with current calcium intake, alcohol consumption,
current standing, sportive activity, level of spinal cord
lesion, presence or absence of spasticity, smoking, or
history of fracture(s) after SCI.
QUI.CALC was positively correlated with BMD of
FN, TDIA, and TEPI (p<0.0001 for all regressions).
The highest coeﬃcient of correlation was achieved with
BMD at TEPI (r=0.72). Similarly, SOS.TIB was posi-
tively correlated with BMD at infralesional sites
(p<0.005), the highest correlation being found with
BMD at TDIA (r=0.53). AdSOS.PHAL correlated
positively with BMD of both subregions of the arms:
i.e., 1/3R and UDR (r=0.24; p<0.05, for both).
Biochemistry
Generally speaking, markers of bone resorption (D-
pyr/Cr, Ca/Cr) were dramatically increased in recently
injured paraplegics, whereas bone formation
markers (ALP, OC) were either slightly elevated or
within the upper reference range (Fig. 4). While the
majority of patients injured for more than 1 year
showed normal bone formation markers, bone
resorption estimated by D-pyr/Cr ratio remained ele-
vated in 50% and 30% of paraplegics in stratum II
(1–9 years post-SCI) and strata III–IV (10 years or
more post-SCI), respectively.
In recently injured paraplegics, serum Ca++, P, and
UCaxV were elevated and serum levels of intact PTH
initially suppressed. In patients >1 year after SCI, these
parameters were within normal range (data not shown).
Serum Ca++ and OC decreased signiﬁcantly with age
(r=0.34 and 0.44, respectively; both p<0.001) and with
time-after-injury (r=0.34 and 0.37, respectively; both
p<0.001). Serum intact PTH increased with age
(r=0.42; p<0.0001) and with time-since-injury (r=0.44;
p<0.0001). D-pyr/Cr, Ca/Cr, ALP, P, and UCaxV de-
creased with time-since-injury but not with age. Serum
25OHD and UCrxV were independent of both time-
since-injury and age. In three cases, 25OHD levels were
slightly below the reference range. No other parameters
such as weight, nutrition, or physical activity were found
to inﬂuence biochemical markers of bone metabolism.
After controlling for age and time-since-injury, pa-
tients with anamnestic fracture(s) after SCI had signiﬁ-
Fig. 1 Cumulative fracture rate (triangles) and fracture incidence
(rectangles) observed in 1,010 patient-years among 98 paraplegic
men 0–30 years after spinal cord injury
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cantly lower OC serum concentrations (p<0.05) and
signiﬁcantly higher D-pyr/Cr (p<0.05).
Discussion
This cross-sectional study is the ﬁrst to document the
fracture history, regional evolution of BMD (infra- and
supralesional / trabecular and cortical) and QUS
parameters as well as biochemical parameters of bone
turnover in a large (98 patients) and homogeneous (men
with complete motor post-traumatic medullary lesion)
group of SCI patients.
In the present study, fractures occurred exclusively at
the lower extremities, numerically more frequently at the
tibia, an observation which is in accordance with that of
others [2]. The fractures did not occur in the ﬁrst 3 years
after injury, although 40% of trabecular bone had al-
ready been lost at that time and the curve of trabecular
bone loss had even leveled oﬀ. The median duration to
ﬁrst fragility fracture was 8.5 years, a point in time
where the BMD of the tibial cortex had reached a mean
Z-score of –2.5 SD. In addition, the largest diﬀerence in
terms of BMD Z-score between paraplegics with and
those without a history of fractures, was found at the
tibial diaphysis (i.e., 1.9 SD), a predominantly cortical
site. The chronic cortical demineralization process,
including at the tibia, could at least partly explain the
late but frequent occurrence of fragility fractures in the
present population of paraplegic men. These fracture
Fig. 2 BMD Z-scores (SD) at
various skeletal sites as a
function of time since spinal
cord injury in 98 paraplegic
men
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data compare well with those recently collected from 438
paraplegics of the Danish Paraplegic Association and
from 654 randomly selected normal controls using self-
administered questionnaires[2]. They found a crude
fracture incidence of 2% per year in paraplegics: i.e., a
twofold increase compared with controls (p<0.001)
which is similar to the yearly incidence of fracture epi-
sodes of 2.2% reported in this study. They reported a
median time-since-injury of 11 years in females and
12 years in males, which is slightly longer than reported
here and may be due to the neurologic heterogeneity of
the included patients (complete or partial paralysis).
Earlier studies reported fracture incidences between 4%
[21, 22] and 11% [23], without mentioning the time point
of observation after SCI.
A new ﬁnding is the diﬀerential pattern of sublesional
bone loss in paraplegics with respect to trabecular and
cortical bone compartments. Until today, BMD in
paraplegics has not been measured in skeletal sites more
distal to the femur. In this study we measured the BMD
at distal tibia [17]. The BMD at the mainly trabecular
TEPI site and at the mainly cortical TDIA site, with all
the precautions required due to the cross-sectional de-
sign, seems to have followed a diﬀerent decrease pattern
in paraplegic men: the tibial epiphysis, and to a lesser
extent femoral neck—both containing a substantial part
of trabecular bone—showed early and rapid deminer-
alization which leveled oﬀ within the ﬁrst 3 years after
injury. In contrast, the tibial diaphysis—containing al-
most exclusively cortical bone [17]—showed a slower but
Fig. 3 Quantitative ultrasound
parameters (absolute values and
corresponding Z-scores) at
various skeletal sites as a
function of time since spinal
cord injury in 98 paraplegic
men
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continuous demineralization which proceeded even be-
yond 10 years postinjury. This eﬀect is previously
undescribed, although it was recently suggested that
bone loss at pelvis and legs could continue to decline
linearly throughout the chronic phase of immobilization
in male monozygotic twin pairs—one twin of each pair
having SCI [13]. Other cross-sectional studies were either
too small or too heterogeneous to detect the eﬀect [11,
12, 14].
The ﬁndings from quantitative ultrasound measure-
ments were entirely consistent with BMD results, not
only with respect to distinction of bone loss at cortical vs
trabecular sublesional sites but also with respect to
preservation of bone mass at the upper limbs. There was
a high correlation between BMD at tibial epiphysis and
QUI.CALC, and BMD at tibial diaphysis and SOS.TIB.
Quantitative ultrasound is partly determined by bone
mass. However, SOS is also a function of elasticity
whereas BUA may be related to bone structure [18].
Whether the observed changes add the dimension of
deterioration of bone quality to the BMD results in
patients after SCI cannot be concluded from this study.
However, these results are consistent with those from
Chow et al. using an Achilles device at the calcaneus
[16]. Studies using other than calcaneal devices are
lacking.
The results on biochemical parameters suggest that
an imbalance between elevated bone resorption and
normal (to low) bone formation after SCI plays a role in
the pathogenesis of bone loss and fracture in paraplegic
men. Bone resorption was dramatically increased early
(<1 year) after SCI with an almost ﬁvefold elevated
mean urinary D-pyr/ Cr and Ca/Cr, while bone forma-
tion lay within the (upper) reference range. Further-
more, in the acute stage (stratum I), there was no
correlation between resorption and formation parame-
ters, pointing to an uncoupling of the two processes. The
fact that—despite counterregulatory suppression of
serum intact PTH, and increase of renal calcium excre-
tion—frank hypercalcemia occurred in 50% of recently
injured men (stratum I), indicates how excessively bone
was resorbed. The present data are in accordance with
the ﬁndings of a recent small longitudinal follow-up
study over 6 months in para- and tetraplegics early after
SCI [4]. Two older studies reported that hydroxypro-
linuria returned towards baseline 6 to 12 months after
SCI [24, 25]; another study suggested that high bone
resorption was ongoing for up to 3 to 5 years after SCI,
based on indirect evidence (suppressed PTH levels) in a
cross-sectional setting [26]. As an unexpected ﬁnding,
30% of the paraplegics in strata III and IV (i.e.,
>10 years after SCI) showed an elevated bone resorp-
tion activity, and—similar to the ﬁnding in stratum
I—the bone formation markers did not show a signiﬁ-
cant correlation with resorption markers at that chronic
stage. Paraplegics of strata III+IV with high resorption
markers had furthermore lower BMD Z-scores at the
tibial sites and had approximately 4 times more often a
history of fragility fracture compared with chronic
paraplegics with normal D-pyr/Cr ratios. Thus, it can be
assumed that in 30% of chronic paraplegics, excessive
bone resorption had been persisting over a longer period
of time and did not represent an accidental or transitory
ﬁnding. Furthermore, paraplegics with a history of
Fig. 4 Evolution of biochemical
parameters of bone resorption
and bone formation as a
function of time since spinal
cord injury in 98 paraplegic
men
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fracture had signiﬁcantly lower osteocalcin serum levels
compared with the nonfractured.
The BMD and QUS results of the present study show
that bone loss after SCI is not a systemic process but a
process restricted to unloaded skeletal sites. These clin-
ical ﬁndings are in line with the hypothesis of Frost and
others [27, 28] stating that mechanical unloading induces
the increased bone resorption by suppressing an inhibi-
tory control on osteoclasts and that—in the absence of
mechanical strain—formation cannot cope with this in-
creased bone resorption. Using human iliac bone mar-
row cultures of paraplegic patients, Demulder et al. [29]
have recently shown an increase of osteoclast-like cell
formation below the lesional level which they explained
by locally elevated IL-6 production arising from modi-
ﬁcations in the bone marrow microenvironment in the
paralyzed territories. Neurovascular changes secondary
to the modiﬁcation of the autonomic nervous system [24]
with decreased local release of neuropeptides (such as
calcitonin gene-related peptide) that inhibit bone
resorption could directly contribute to the increased
resorption activity after SCI [30].
This cross-sectional study documents the time course
and the clinical consequences of bone loss after spinal cord
injury in ahomogeneous groupofmale paraplegics. Based
on DXA, ultrasound, and biochemical measurements it
seems reasonable to assume that infralesional bone loss is
based on increased bone resorption with uncoupled bone
formation and is a continuous process, at least in the
cortical bone compartment. Based on the high burden of
illness represented by fragility fractures in these patients,
longitudinal studies should be designed to gain a better
understanding of the pathophysiology of the disease and
of possible treatment interventions.
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